← Evidence map

ArticleFrontiers in pharmacology2024

Mg-ZIF nanozymes disrupt the level of ROS for osteosarcoma killing via POD activity.

Junjie Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38769996